Spain· ES:86688
DESVENLAFAXINA ALTER 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
A desvenlafaxine product containing desvenlafaxina, registered in Spain by Laboratorios Alter S.A.. The same ATC class is registered in 5 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Desvenlafaxine is registered in 5 of 19 countries.
Countries holding a registration under ATC N06AX23 (desvenlafaxine), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 3 of them publish a price we can compare per daily dose
Desvenlafaxine · ATC N06AX23
5 / 19 countries
- Canada
- Germany
- Spainprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of desvenlafaxine costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $0.41 in Spain to $0.82 in Switzerland — a ×2.0 gap.
- Spain: $0.41 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Desvenlafaxine · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.82
- ES Spain$0.41
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- desvenlafaxina
- Manufacturer
- Laboratorios Alter S.A.
- Country
- Spain (ES)
- ATC code
- N06AX23
- ATC class
- Desvenlafaxine
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- August 12, 2026
Packs & prices · 1
1 priced- cima_codigo73313428EUR 10.19
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
242 interactions on record for desvenlafaxine.
Graded by severity as the source publishes them — 25 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Desvenlafaxine · interactions on record
242 records
- 25 severe
- 196 moderate
- 1 minor
- 20 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Desvenlafaxine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesdesvenlafaxineDIRECT RX
- CanadaAG-DESVENLAFAXINEANGITA PHARMA INC.
- SwitzerlandDesveneurax 50 mg, RetardtablettenNeuraxpharm Switzerland AG
- GermanyDesveneuraxNeuraxpharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Desveneurax
- Cyprus · Desvenlafaxine Adelco
- Germany · Desveneurax, Desvenlafaxin Waymade
- Greece · Desvenlafaxine Adelco
- Italy · Faxilex
- Malta · Desvenlafaxine Alembic, Desvenlafaxine Waymade
- Portugal · Fasilex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b13ce341-115e-4c33-bf74-d5c30b14892d GET /v1/drugs/b13ce341-115e-4c33-bf74-d5c30b14892d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1647865661000}",
"nregistro": "86688",
"substance": "desvenlafaxina"
}See everything about desvenlafaxine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.